Cargando…
Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised phase II trial
PURPOSE: This study aims to evaluate the efficacy and safety of laser photobiomodulation (PBM) for treatment of established chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors. METHODS: We conducted a randomised phase II, non-comparative, sham-controlled, single-blinded clinical tr...
Autores principales: | Teng, Christina, Egger, Sam, Blinman, Prunella L., Vardy, Janette L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758032/ https://www.ncbi.nlm.nih.gov/pubmed/36526802 http://dx.doi.org/10.1007/s00520-022-07463-y |
Ejemplares similares
-
How long is too long? A scoping review of health system delays in lung cancer
por: Malalasekera, Ashanya, et al.
Publicado: (2018) -
“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022) -
The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial)
por: Joy, Lodewijckx, et al.
Publicado: (2022) -
Chemotherapy-induced peripheral neuropathy. Part II. Prevention
por: Brzeziński, Krzysztof
Publicado: (2012) -
Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial
por: Blinman, Prunella, et al.
Publicado: (2016)